International Business News - Schering http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Schering-Plough Corp., a major maker of prescription drugs and consumer health products, spent $530,000 in the second quarter to lobby on federal reimbursement, generic drugs, patents and other issues, according to a recent disclosure report. http://www.ibtimes.com/articles/20080829/schering-plough-spent-530-000-lobbying-in-2q.htm Fri, 29 Aug 2008 17:25:49 EDT U.S. drug maker Schering-Plough Corp. won EU approval Wednesday to sell off several animal vaccines and medicines to rival Pfizer Corp., obeying an earlier EU antitrust order to offload some assets before it could buy another pharmaceutical business. http://www.ibtimes.com/articles/20080827/schering-plough-eu-oks-product-sale-to-pfizer.htm Wed, 27 Aug 2008 11:45:04 EDT Fitch Ratings lifted a negative rating watch on drug maker Schering-Plough Corp., citing more certainty related to debt it took on to buy a health products manufacturer. http://www.ibtimes.com/articles/20080814/fitch-lifts-rating-watch-on-schering-plough.htm Thu, 14 Aug 2008 18:20:16 EDT Fitch Ratings lifted a negative rating watch on drug maker Schering-Plough Corp., citing more certainty related to debt it took on to buy a health products manufacturer. http://www.ibtimes.com/articles/20080814/fitch-lifts-rating-watch-on-schering-plough.htm Thu, 14 Aug 2008 16:41:09 EDT Drug developer Schering-Plough Corp. said Tuesday it bought two of its former partners in China, further solidifying its position in one of the world's fastest growing economies. http://www.ibtimes.com/articles/20080812/schering-plough-buys-former-chinese-partners.htm Tue, 12 Aug 2008 10:19:57 EDT Among the premarket stories for Friday, August 1, from AP Financial News: NEW YORK (AP)_ Shares of drug maker Schering-Plough Corp. fell in premarket trading Friday following the Food and Drug Administration's surprise rejection of the company's anesthesia-recovery treatment. http://www.ibtimes.com/articles/20080801/premarket-roundup-schering-plough-urban-outfitters.htm Fri, 01 Aug 2008 08:23:46 EDT Shares of drug maker Schering-Plough Corp. fell in premarket trading Friday following the Food and Drug Administration's surprise rejection of the company's anesthesia-recovery treatment. http://www.ibtimes.com/articles/20080801/ahead-of-the-bell-schering-plough.htm Fri, 01 Aug 2008 08:06:20 EDT Government regulators dealt a major setback to Schering-Plough Corp., rejecting a highly anticipated drug designed to help patients recover from anesthesia. http://www.ibtimes.com/articles/20080801/fda-rejects-schering-drug-to-reverse-anesthesia.htm Fri, 01 Aug 2008 18:37:29 EDT Shares of Schering-Plough Corp. climbed Thursday after scientists reported that animal testing of a company drug showed a miraculous ability to reduce fat. http://www.ibtimes.com/articles/20080731/schering-shares-up-on-promise-of-exercise-drug.htm Thu, 31 Jul 2008 15:02:02 EDT Vytorin partners Merck & Co. and Schering-Plough Corp. have prepared a letter for physicians who might be concerned over recent study results that showed patients taking the cholesterol drug were at higher risk of dying from cancer. http://www.ibtimes.com/articles/20080723/merck-and-schering-plough-prepare-vytorin-letter.htm Wed, 23 Jul 2008 16:29:22 EDT Shares of drugmaker Merck & Co. continued to fall Tuesday, a day after the second study in six months cast doubts on the effectiveness of the blockbuster combination cholesterol pill Vytorin it sells with partner Schering-Plough Corp. http://www.ibtimes.com/articles/20080722/merck-shares-way-down-schering-recovering.htm Tue, 22 Jul 2008 19:28:29 EDT Schering-Plough Corp.'s second-quarter profit tumbled 23 percent on charges for a canceled development program with Merck & Co. and accounting adjustments, but adjusted profit topped Wall Street forecasts. http://www.ibtimes.com/articles/20080721/schering-plough-2q-profit-falls-on-charges.htm Mon, 21 Jul 2008 17:48:30 EDT In the latest disappointment over cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. Its makers' shares plunged about 15 percent. http://www.ibtimes.com/data/articleimgs/94980-schering-plough-merck-delay.jpg http://www.ibtimes.com/articles/20080721/schering-plough-mercks-vytorin-misses-main-goal.htm http://www.ibtimes.com/articles/20080721/schering-plough-mercks-vytorin-misses-main-goal.htm Mon, 21 Jul 2008 19:34:45 EDT Shares of Merck & Co. and Schering-Plough Corp. fell Monday morning after the companies said they will report data from a clinical trial of cholesterol drugs Vytorin this afternoon. http://www.ibtimes.com/articles/20080721/merck-and-schering-fall-ahead-of-vytorin-data.htm Mon, 21 Jul 2008 19:17:02 EDT Drugmakers Schering-Plough Corp. and Merck & Co. took the highly unusual step of delaying their second-quarter results until after the closing bell Monday so European researchers can present data from a study of the companies' cholesterol drug Vytorin. http://www.ibtimes.com/articles/20080721/merck-and-schering-delay-2q-reports-to-afternoon.htm Mon, 21 Jul 2008 12:29:35 EDT Schering-Plough Corp., a major drug and consumer health products maker, reports earnings for the second quarter on Monday morning. The following is a summary of key developments and analyst opinion related to the period. http://www.ibtimes.com/articles/20080718/earnings-preview-schering-plough.htm Fri, 18 Jul 2008 16:06:57 EDT Schering-Plough Corp. shares edged up Tuesday after a Lehman Brothers analyst raised his rating to "Buy," saying the drug maker will post better profit and revenue growth than its rivals through 2012. http://www.ibtimes.com/articles/20080715/ahead-of-the-bell-schering-plough-inches-up.htm Tue, 15 Jul 2008 09:12:26 EDT Schering-Plough Corp. said Friday its drug Pegintron showed mixed results in a study on late-stage cancer patients, as it improved the amount of time a patient survives without relapsing, but not the overall survival rate. http://www.ibtimes.com/articles/20080711/schering-plough-drug-improves-cancer-relapse-rate.htm Fri, 11 Jul 2008 13:53:20 EDT Schering-Plough Corp. and Merck & Co. said Friday they are withdrawing an application for a combination allergy drug containing Schering's Claritin and Merck's Singulair. http://www.ibtimes.com/articles/20080627/schering-plough-merck-pull-drug-application.htm Fri, 27 Jun 2008 08:39:28 EDT Drug developer Schering-Plough Corp. spent $520,000 in the first quarter to lobby on patent reform legislation, drug safety and other issues, according to a disclosure report. http://www.ibtimes.com/articles/20080617/schering-ploughs-1q-lobbying-reached-520-000.htm Tue, 17 Jun 2008 10:55:49 EDT